---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274536017.md"
description: "Novo Nordisk announced the main clinical trial results of Reimagine 2. Novo Cagrisema demonstrated a weight loss effect of up to 14.2%. Cagrisema shows better weight loss effects compared to Semaglutide"
datetime: "2026-02-02T15:45:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274536017.md)
  - [en](https://longbridge.com/en/news/274536017.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274536017.md)
---

# 

Novo Nordisk announced the main clinical trial results of Reimagine 2.  
Novo Cagrisema demonstrated a weight loss effect of up to 14.2%.  
Cagrisema shows better weight loss effects compared to Semaglutide

### Related Stocks

- [688710.CN](https://longbridge.com/en/quote/688710.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [688105.CN](https://longbridge.com/en/quote/688105.CN.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [301333.CN](https://longbridge.com/en/quote/301333.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)

## Related News & Research

- [Mitsui to supply e-methanol to OMV for land transport fuel under RFNBO deal](https://longbridge.com/en/news/296423772.md)
- [Novo CEO says obesity market won't be winner-take-all battle with Lilly](https://longbridge.com/en/news/295777893.md)
- [Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst](https://longbridge.com/en/news/295556682.md)
- [Septerna Q2 revenue beats analyst estimates, driven by Novo Nordisk partnership](https://longbridge.com/en/news/295444112.md)
- [Novo Nordisk Expands Treasury Position as 2026 Share Buyback Nears DKK 8 Billion](https://longbridge.com/en/news/295426032.md)